Related Experiment Video
Updated: Jun 5, 2026
06:08
Evaluation of Drug Sorption to PVC- and Non-PVC-based Tubes in Administration Sets Using a Pump
Published on: March 11, 2017
Paediatric pharmacology: remember the excipients
Pharmacological Research
|January 19, 2011
Summary
Pharmaceutical excipients are crucial for drug formulation, especially in pediatric medicines. Growing evidence shows these substances are not inert and raise safety concerns, particularly for children.
Area of Science:
- Pharmaceutical Sciences: Focuses on the role and safety of excipients in drug formulation and delivery.
Background:
- Excipients are integral to the pharmaceutical industry, providing essential properties like preservation, stability, and physical form to medications.
- They are particularly critical in pediatric formulations, influencing the development of suitable drug products for children.
Discussion:
- Historically considered inert, excipients are now recognized as pharmacologically active components.
- There is increasing concern regarding the safety profiles of excipients, especially with their widespread use in pharmaceutical manufacturing.
- The safety of excipients in pediatric drug formulations warrants particular attention due to potential unique physiological responses in children.
Key Insights:
- Excipients are not inert and possess biological activity.
- The safety of excipients, especially in pediatric populations, is a growing area of concern.
- Rethinking the role of excipients from inactive fillers to active components is essential for drug development.
Outlook:
- Further research is needed to fully elucidate the safety and potential activity of various excipients in different patient populations.
- Development of novel excipients with improved safety profiles for pediatric use is a key future direction.
- Regulatory bodies and pharmaceutical manufacturers must collaborate to ensure the safe and effective use of excipients in all drug products.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:19Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...